BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SenzaGen - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SenzaGen
X-ORIGINAL-URL:https://senzagen.com
X-WR-CALDESC:Events for SenzaGen
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210902
DTEND;VALUE=DATE:20210903
DTSTAMP:20210824T092518Z
CREATED:20210315T135907Z
LAST-MODIFIED:20210824T092518Z
UID:25927-1630540800-1630627199@senzagen.com
SUMMARY:WC11
DESCRIPTION:11th World Congress on Alternatives and Animal Use in the Life Sciences\n23 August – 2 September 2021 | Virtual Congress\n  \n\n\n\n\nPosters open for viewing: \n Aug 10 – Sep 2\n\n\n\n# P471 \nAbstract ID 961\nQuantitative sensitizing potency assessment using GARDskin Dose-Response\nDr Henrik Johansson\n\n\n\n\n\n\n\n# P140 \nAbstract ID 334\nThe GARDpotency assay for potency-associated subclassification of chemical skin sensitizers – rationale\, method development and ring trial results of predictive performance and reproducibility\nDr Henrik Johansson\n\n\n\n\n\n\n\n# P146 \nAbstract ID 346\nReliable and truly animal-free skin sensitization testing – adaption of the in vitro GARDskin assay to animal-free conditions\n Dr Andy Forreryd\n\n\n\n\n\n\n\n# P147 \nAbstract ID 348\nHazard assessment of photoallergens using GARDskin\nDr Andy Forreryd\n\n\n\n\n\n\n\n\nTwo dedicated poster sessions for live Q&A:  \nAug 27\,  18.00 – 19.30  ;   Aug 31\,  17.15 – 18.15\n\n\n\n\n\n\n\n\n\n🌎Invited presentation at OECD & EURL ECVAM Joint Session \nAug 30\, 15.00 – 17.00\n\n\n\nAbstract ID 331\n\nTransferability challenges with modern technology and how to overcome them – a case study of the GARD assays from a test method developer’s perspective \nMO-1  S59:  Innovative technologies integrating standardised regulatory test methods: challenges and perspectives \nTheme: Innovative Technologies \n \nDr Henrik Johansson\n\n\n\n 
URL:https://senzagen.com/event/wc11/
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2021/03/WC11-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20210916T160000
DTEND;TZID=Europe/Stockholm:20210916T170000
DTSTAMP:20210826T142827Z
CREATED:20210826T102829Z
LAST-MODIFIED:20210826T142827Z
UID:27453-1631808000-1631811600@senzagen.com
SUMMARY:Webinar: How is GARD used for skin sensitization testing?
DESCRIPTION:User cases on hazard and potency assessment\nGiven the huge interest in our previous webinar on GARD user cases\, we are pleased to offer you a new opportunity to hear how our customers use GARD to fill data gaps in sensitizing hazard and potency assessment of chemicals and medical devices. \n\nKey topics\nWe will provide several user cases on how the GARD assays have been used for skin sensitization testing to demonstrate: \n\nHazard assessment of “difficult-to-test” samples such as complex mixtures and surfactants.\nSensitization information for risk assessment of medical devices and solid materials.\nPotency determination for both CLP classification and product development.\n\nThe webinar should last around 40 minutes\, followed by a live Q&A. If you cannot attend the live event\, register now to get access to the recording of this webinar. \nSpeakers\n  \n\nRegister now
URL:https://senzagen.com/event/new-opportunity-how-is-gard-used-for-sensitization-testing/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2021/08/webinar-banner-cropped.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210930
DTEND;VALUE=DATE:20211005
DTSTAMP:20210930T105113Z
CREATED:20210408T090913Z
LAST-MODIFIED:20210930T105113Z
UID:26194-1632960000-1633391999@senzagen.com
SUMMARY:Eurotox
DESCRIPTION:Eurotox 2021 Virtual Congress\n27 September – 1 October\n  \n\n\n\n\n🌎Industry symposium hosted by SenzaGen \nSep 29\, 17.30 – 18.30\n\n\n\n\n\nFilling data gaps in skin sensitization testing: in vitro hazard and potency assessments using GARD \n\nDr Andy Forreryd \nDr Henrik Johansson\n\n\n\n\nGARDskin and GARDpotency: a proof of concept study to investigate the applicability domain for agrochemical formulations \n\nGuest Speaker\nMarco​ Corvaro\, Corteva Agriscience\n\n\n\n\n\nAssessment of the skin sensitizing potential of pandemic-associated medical devices using the GARDskin Medical Device assay \n\nGuest Speaker\nPeter Mohlin\, Essity Hygiene & Health AB\n\n\n\n\n\n\n\n  \n \n🌎Presentation at Session 12 – Symposium\nSep 28\, 16.30 – 18.30\n\n\n\n\n\nGenomics-based platforms in combination with machine learning algorithms enabling well informed and reliable risk assessments for different toxicological endpoints \nSession 12– Symposium: Application of high throughput transcriptomics in mechanism-based chemical safety assessment\nDr Andy Forreryd\n\n\n\n\n\n\n\n\nPosters open for viewing: \n Sep 27 – Oct 1\n\n\n\n# P23-11 \nAbstract ID 140\nQuantitative sensitizing potency assessment using GARDskin Dose-Response\nDr Henrik Johansson\n\n\n# P04-10 \nAbstract ID 164\nApplicability domain of the GARDskin Medical Device test for in vitro skin sensitization testing of medical devices\nDr Rose-Marie Jenvert \n \n\n\n# P04-30 \nAbstract ID 390\nIn vitro assessment of the skin sensitizing potential and potency of epoxy resin monomers and pre-polymer mixtures using the GARD assay\nDr Helge Gehrke\, Eurofins\n\n\n# P23-34 \nAbstract ID 402\nAssessment of the skin sensitizing potential of pandemic-associated medical devices using the GARDskin Medical Device assay\nPeter Mohlin\, Essity
URL:https://senzagen.com/event/eurotox-2/
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2021/04/eurotox2021.jpg
END:VEVENT
END:VCALENDAR